Acorah Software Products - Accounts Production 16.5.460 false true false true No description of principal activity 15 February 2024 31 March 2025 31 March 2025 15491493 Mrs Sarah Richardson Mr Anthony Richardson iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15491493 2024-02-14 15491493 2025-03-31 15491493 2024-02-15 2025-03-31 15491493 frs-core:CurrentFinancialInstruments 2025-03-31 15491493 frs-bus:PrivateLimitedCompanyLtd 2024-02-15 2025-03-31 15491493 frs-bus:FilletedAccounts 2024-02-15 2025-03-31 15491493 frs-bus:Micro-entities 2024-02-15 2025-03-31 15491493 frs-bus:AuditExempt-NoAccountantsReport 2024-02-15 2025-03-31 15491493 frs-bus:Director1 2024-02-15 2025-03-31 15491493 frs-bus:Director2 2024-02-15 2025-03-31
Registered number: 15491493
SR Pharma Research Limited
Unaudited Financial Statements
For the Period 15 February 2024 to 31 March 2025
Property Accounts Limited
SR Pharma Research Limited
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 15491493

| 31 March 2025
--- | ---
|  | £
Current assets |  | 44,228
Creditors: Amounts Falling Due Within One Year |  | (10,253 )
NET CURRENT ASSETS |  | 33,975
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 33,975
NET ASSETS |  | 33,975
CAPITAL AND RESERVES |  | 33,975

## Notes

1. General Information
SR Pharma Research Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15491493 . The registered office is c/o Property Accounts Limited, 59 Castle Street, Reading, RG1 7SN.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Mrs Sarah Richardson Director
05/09/2025